| Pharmaceutical active ingredients: |
| Selegiline Hydrochloride |
| Available forms, composition and doses of Xilopar: |
| Tablets; Oral; Selegiline Hydrochloride 1.25 mg |
| Xilopar medical category: |
| Human:Antiparkinsonian drugsCentral nervous system agentsMonoamine Oxidase B inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BD01 - Selegiline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Elan PharmaceuticalsCephalonEsteve FarmaSegix Italia |